0
Signin
countryflagCA

888-969-2592

RY 178.99 1.5488% SHOP 160.81 0.7392% TD 75.42 -5.3226% ENB 61.85 0.7657% BN 84.99 -0.4568% TRI 237.89 0.3332% CNQ 46.76 0.3864% CP 107.17 -0.177% CNR 153.67 -0.376% BMO 137.97 2.8476% BNS 77.79 -0.0129% CSU 4695.5 -0.8445% CM 93.5 4.3876% MFC 46.04 1.3874% ATD 82.52 -0.2297% NGT 56.55 -2.8517% TRP 68.97 0.0871% SU 55.12 1.8477% WCN 267.67 -0.4352% L 193.3 3.463%

Aequus Pharmaceuticals Inc

Healthcare CA AQS

0.005CAD
-(-%)

Last update at 2024-12-04T14:30:00Z

Day Range

0.0050.005
LowHigh

52 Week Range

0.010.04
LowHigh

Fundamentals

  • Previous Close 0.005
  • Market Cap1.99M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-2.56421M
  • Revenue TTM0.41M
  • Revenue Per Share TTM0.003
  • Gross Profit TTM 2.69M
  • Diluted EPS TTM-0.01

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31
Type yearly yearly yearly yearly yearly
Date 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31
Income before tax -1.80959M -1.04536M -3.10610M -2.80374M -3.88243M
Minority interest - - - - -
Net income -1.80959M -1.04536M -3.10610M -2.80374M -3.88243M
Selling general administrative 3.63M 2.96M 3.64M 3.69M 4.06M
Selling and marketing expenses - - - - -
Gross profit 2.69M - - 1.41M 1.14M
Reconciled depreciation 0.13M 0.21M 0.31M 0.19M 0.19M
Ebit -1.60753M -0.77980M -2.44132M -2.80803M -4.00246M
Ebitda -1.22664M -0.31480M -2.37837M -2.62024M -3.72531M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -1.36745M -0.52610M -2.21789M -2.80803M -3.91253M
Other operating expenses - - - - -
Interest expense 0.45M 0.52M 0.42M 0.00000M 0.00000M
Tax provision - - - - 0.00000M
Interest income 0.01M 0.00453M 0.00948M 0.00531M 0.01M
Net interest income -0.44166M -0.51506M -0.40919M 0.00531M 0.01M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - 0.00000M
Total revenue 2.71M 2.59M 1.63M 1.41M 1.14M
Total operating expenses 4.08M 3.12M 3.85M 4.22M 5.05M
Cost of revenue 0.03M - - - 0.00000M
Total other income expense net -0.00048M -0.00420M -0.47902M -0.00102M 0.02M
Discontinued operations - - - - -
Net income from continuing ops -1.80959M -1.04536M -3.10610M -2.80374M -3.88243M
Net income applicable to common shares -1.80959M -1.04536M -3.10610M -2.80374M -3.88243M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 1.09M 1.69M 4.35M 3.13M 1.67M
Intangible assets - - - - 0.08M
Earning assets - - - - -
Other current assets 0.07M 0.20M - - -
Total liab 5.38M 3.07M 2.56M 2.56M 2.55M
Total stockholder equity -4.29384M -1.38004M 1.79M 0.57M -0.87709M
Deferred long term liab